84 articles
Ethan Settembre, PhD, Vice President, Research, CSL R&D Seqirus Vaccines Innovation Unit and study author, discusses key findings from the data publishe...
Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the news that Takeda’s dengue vaccine candidate, TAK-003, was r...
Jan Poolman, Head Bacterial Vaccine Discovery and Early Development at Janssen Infectious Diseases and Vaccines, at the Janssen Pharmaceutical Companies...
Daniel Faden, MD, Assistant Professor of Otolaryngology-Head and Neck Surgery, Harvard Medical School discusses his research on patient knowledge and op...
Returning guest, Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda, discusses the approval of the company’s dengue vaccine,...
Gregg Sylvester, Chief Health Officer at CSL Seqirus, one of the world’s largest influenza providers, discusses the CDC’s Advisory Committee on Imm...
Pascale Leroueil, Vice President of Healthcare at the William Davidson Institute at the University of Michigan discusses a recent study where she and co...
The CDC’s Advisory Committee on Immunization Practices (ACIP) is currently reviewing enhanced influenza vaccines (EIV), which are shots recommended to...
Jeff Skolnik, Senior Vice President of Clinical Development at INOVIO Pharmaceuticals, discusses the current research and development of a DNA vaccine f...
Elizabeth Profita, MD, a pediatric cardiologist at Stanford Children's Health discusses how to weigh the risks and benefits of COVID-19 vaccination in d...